Konstantinos Porpodis Selected Research

Konstantinos Porpodis Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 01/2012
12	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2012
10	Asthma (Bronchial Asthma) 10/2022 - 08/2009
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2013
5	Chronic Obstructive Pulmonary Disease (COPD) 05/2019 - 01/2013
4	Neoplasm Metastasis (Metastasis) 04/2020 - 08/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2012
4	Disease Progression 01/2019 - 01/2013
3	Inflammation (Inflammations) 01/2019 - 01/2013
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 01/2015
2	Dyspnea (Shortness of Breath) 05/2019 - 06/2017
2	Adenocarcinoma 01/2017 - 02/2015
2	Carcinoid Tumor (Carcinoid) 01/2016 - 01/2012
2	Pulmonary Hypertension 01/2014 - 01/2011
1	COVID-19 10/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2021
1	Obstructive Sleep Apnea 12/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Carcinogenesis 01/2020
1	Persistent Infection 01/2020
1	Bursitis (Adhesive Capsulitis) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Weight Loss (Weight Reduction) 05/2016
1	Postoperative Pain 01/2016
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2015
1	Emphysema 11/2014
1	Allergic Bronchopulmonary Aspergillosis 10/2014
1	Hemoptysis 10/2014
1	Pneumothorax 10/2014
1	Cystic Fibrosis (Mucoviscidosis) 08/2014
1	Crohn Disease (Crohn's Disease) 08/2014
1	Malnutrition (Nutritional Deficiencies) 08/2014
1	Ulcerative Colitis 08/2014

Drug/Important Bio-Agent (IBA)

3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 01/2015
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2014
3	Methacholine Chloride (Methacholine)FDA Link 01/2021 - 08/2009
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2013
3	PlatinumIBA 01/2017 - 01/2013
2	Biological ProductsIBA 10/2022 - 03/2014
2	mepolizumabIBA 09/2022 - 01/2020
2	Omalizumab (Xolair)FDA Link 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 01/2020
2	SteroidsIBA 01/2021 - 06/2017
2	Carboplatin (JM8)FDA LinkGeneric 02/2020 - 01/2013
2	AsbestosIBA 01/2020 - 01/2012
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019 - 01/2015
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2019 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 01/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014 - 01/2013
2	AerosolsIBA 01/2014 - 01/2012
1	Circular RNAIBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Long Noncoding RNAIBA 07/2020
1	norvalineIBA 04/2020
1	Sunitinib (Sutent)FDA Link 04/2020
1	Ki-67 Antigen (Ki 67 Antigen)IBA 04/2020
1	Pyruvic Acid (Pyruvate)IBA 02/2020
1	Transcription Factors (Transcription Factor)IBA 02/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Interleukin-5 (Interleukin 5)IBA 01/2020
1	GoldIBA 05/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	CytokinesIBA 01/2019
1	Chromogranin AIBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Insulin-Like PeptidesIBA 01/2019
1	technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotideIBA 01/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 06/2017
1	Bronchodilator Agents (Bronchodilators)IBA 06/2017
1	Phosphodiesterase InhibitorsIBA 01/2017
1	Drug CombinationsIBA 01/2017
1	AfatinibIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	AntibodiesIBA 01/2016
1	Tiotropium Bromide (Spiriva)FDA Link 01/2015
1	Muscarinic AntagonistsIBA 01/2015
1	L 644711 (B-3(+))IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Salmeterol Xinafoate (Serevent)FDA Link 01/2015
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2015
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2015
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2015
1	RoflumilastIBA 01/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015
1	somatostatin receptor type 1IBA 01/2015
1	2',3'-dideoxy-5-methylcytidineIBA 11/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014
1	PolymersIBA 08/2014

Therapy/Procedure

15	Therapeutics 12/2021 - 01/2012
12	Drug Therapy (Chemotherapy) 01/2020 - 01/2012
3	Immunotherapy 04/2020 - 01/2013
3	Radiotherapy 01/2020 - 08/2014
2	Conservative Treatment 03/2014 - 01/2012
1	Artificial Respiration (Mechanical Ventilation) 10/2022
1	Continuous Positive Airway Pressure 12/2021
1	Length of Stay 01/2016
1	Thoracotomy 01/2016
1	Enteral Nutrition (Feeding, Tube) 10/2014
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2014